Nucletron, ART partner for image-guided breast irradiation
Nucletron, a radiation oncology company, and Advanced Radiation Therapy (ART) have signed an exclusive, global partnership to offer the AccuBoost system with the microSelectron high-dose rate (HDR) brachytherapy afterloader treatment delivery solution for the treatment of breast cancer.
The partnership offers radiation oncology centers the opportunity to implement ART's technology in image-guided HDR breast brachytherapy on a pay-per-patient pricing model, along with Nucletron's treatment planning, treatment delivery, training, licensing, reimbursement and customized service support.
The Billerica, Mass.-based ART said its expansion of AccuBoost technology through its partnership with the Utrecht, Netherlands-based Nucletron will "reduce the barriers to adoption of brachytherapy for cancer centers previously deterred by the initial start-up costs usually associated with implementing a breast brachytherapy program."
The partnership offers radiation oncology centers the opportunity to implement ART's technology in image-guided HDR breast brachytherapy on a pay-per-patient pricing model, along with Nucletron's treatment planning, treatment delivery, training, licensing, reimbursement and customized service support.
The Billerica, Mass.-based ART said its expansion of AccuBoost technology through its partnership with the Utrecht, Netherlands-based Nucletron will "reduce the barriers to adoption of brachytherapy for cancer centers previously deterred by the initial start-up costs usually associated with implementing a breast brachytherapy program."